Tds Holdings, Inc.
Country not established
- Devices
- 1
What Tds Holdings, Inc. makes
Tds Holdings, Inc. manufactures susceptibility test plates for antimicrobial agents, including ertapenem, used to determine bacterial resistance at specified concentration ranges (0.002–16 µg/mL and 0.015–16 µg/mL) for gram-negative organisms.
These products are classified as Class II medical devices under FDA regulations and are authorised via the 510(k) clearance process. The company is based in the United States.
Catalogue
- Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Tds Holdings, Inc. have in the registry?
The registry currently lists 1 device for Tds Holdings, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Tds Holdings, Inc.'s devices?
Among its 1 most recently registered device, Tds Holdings, Inc. has devices listed in FDA 510(k) (1 device).
What risk classes do Tds Holdings, Inc.'s devices fall under?
Among its 1 most recently registered device, the classes recorded for Tds Holdings, Inc.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Tds Holdings, Inc. in the registry?
The most recently registered devices listed for Tds Holdings, Inc. include SUSCEPTIBILITY TEST PLATE FOR ERTAPENEM 0.002-16UG/ML FOR GRAM NEGATIVE. SUSCEPTIBILITY TEST PLATE FOR ERTAPENEM 0.015-.